A united and urgent call for action: The Gynaecological Cancer Transformation Initiative (GCTI)

For the first time, women with lived experience, leading gynaecological cancer organisations, and Australia’s top clinical and pre-clinical researchers have united to create a bold, national plan: The Gynaecological Cancer Transformation Initiative (GCTI).

Developed over many months of collaboration, the GCTI has been led by ANZGOG, with collaborative partners Ovarian Cancer Australia, the Ovarian Cancer Research Foundation, and other leading organisations.

This is a once-in-a-generation opportunity to revolutionise the way we diagnose, treat, and care for women with gynaecological cancer. Our goal? To significantly reduce the devastating impact of these diseases and save more lives.

Our collective vision is clear: equitable access to world-class healthcare that improves quality of life and survival for every woman affected by a gynaecological cancer.

What is the Gynaecological Cancer Transformation Initiative (GCTI)?

The Gynaecological Cancer Transformation Initiative brings three key and interdependent areas of focus:

The woman’s journey – equitable access to optimal personalised treatment and improved survival, with specialist supportive care.
The clinical team – delivering timely care that is driven by innovative application of technology, research and data.
The research community – a framework for coordinating and integrating gynaecological cancer research for rapid translation into new treatment solutions (bench to bedside).

The Gynaecological Cancer Transformation Initiative would enable:

Expanding access to molecular profiling and precision medicine – personalising diagnosis and treatment and moving away from a one-size-fits-all approach.
Enhancing clinical team capability across Australia including regional and remote areas – access to the latest research, knowledge, treatment and care options
National gynaecological cancers data portal and virtual biobank – facilitating access to samples and information for research
Transforming gynaecological cancer research – increased drug repurposing studies and innovative clinical trials with a focus on new medicines and approaches to treatment
Improved access to specialist supportive care for more

But We Can’t Do It Alone

A $100 million commitment is sought from the Australian Government over four years to change treatment, catalyse research and save women’s lives. The Gynaecological Cancer Transformation Initiative is an exemplar program designed to be delivered in partnership with the Australian Government’s Australian Cancer Plan and the National Framework for Genomics in Cancer Control.